{"id":4033,"date":"2018-10-24T15:35:28","date_gmt":"2018-10-24T15:35:28","guid":{"rendered":"https:\/\/www.americasrehabcampuses.com\/?p=4033"},"modified":"2023-04-11T14:08:06","modified_gmt":"2023-04-11T14:08:06","slug":"fda-may-soon-approve-new-opioid-10-times-stronger-than-fentanyl","status":"publish","type":"post","link":"https:\/\/www.americasrehabcampuses.com\/addiction\/fentanyl\/fda-may-soon-approve-new-opioid-10-times-stronger-than-fentanyl\/","title":{"rendered":"FDA May Soon Approve New Opioid 10 Times Stronger than Fentanyl"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]<\/p>\n

\"\"<\/p>\n

Opioids have contributed to hundreds of thousands of deaths within the last decade, yet drug manufacturers are continuing to release new opioids for the treatment of moderate to severe pain. The FDA is currently in the process of approving a new painkiller called DSUVIA despite the fact the U.S. continues facing a major opioid crisis.<\/p>\n

What is DSUVIA and How Is It Used?<\/h2>\n

DSUVIA is a new drug-device combo with an applicator that deposits painkillers directly under the tongue where the pill is dissolved immediately. DSUVIA, which is made by pharmaceutical company AcelRx, is up to 500 times stronger than morphine and up to 10 times stronger than fentanyl \u2014 the latter of which was involved in\u00a0nearly 30,000 overdose deaths<\/a>\u00a0in 2017.<\/p>\n

If approved, DSUVIA can only be administered by trained healthcare professionals. But many critics fear this drug could end up falling into the wrong hands just like any other opioid and worsen the ongoing opioid crisis. The FDA is expected to make a final decision regarding the approval of DSUVIA no later than November 3, 2018.<\/p>\n

DSUVIA and the Risk for Drug Diversion<\/h2>\n

Drug diversion is defined as the\u00a0deflection of prescription medications<\/a>\u00a0from medical sources into the illegal market. Next to benzodiazepines and prescription stimulants used to treat ADHD, opioids are among the most common types of medications diverted for illegal use. Drug diversion can happen when people steal or buy medications from others, change or sign prescriptions, and visit multiple doctors to get extra prescriptions.<\/p>\n

Though DSUVIA can only be given to patients by healthcare workers, drug diversion could lead to this drug being stolen and used by others. Given the strength of DSUVIA, people who use this opioid just one time face the risk of an instant drug overdose that may not be reversed using overdose antidote drug naloxone. DSUVIA could also fall into the hands of illicit drug makers who create dangerous, duplicate versions of this drug that end up being far more deadly.<\/p>\n

Opioid and Fentanyl Overdose Statistics<\/h2>\n